{"id":"https://openalex.org/W2608486143","doi":"https://doi.org/10.1146/annurev-cancerbio-030617-050430","title":"Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins","display_name":"Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins","publication_year":2017,"publication_date":"2017-10-30","ids":{"openalex":"https://openalex.org/W2608486143","doi":"https://doi.org/10.1146/annurev-cancerbio-030617-050430","mag":"2608486143"},"language":"en","primary_location":{"id":"doi:10.1146/annurev-cancerbio-030617-050430","doi":"https://doi.org/10.1146/annurev-cancerbio-030617-050430","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev-cancerbio-030617-050430","pdf_url":null,"source":{"id":"https://openalex.org/S4210178937","display_name":"Annual Review of Cancer Biology","issn_l":"2472-3428","issn":["2472-3428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Cancer Biology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109504130","display_name":"Kevin G. Coleman","orcid":"https://orcid.org/0009-0009-6445-2931","observed_orcids":["https://orcid.org/0009-0009-6445-2931"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin G. Coleman","raw_affiliation_strings":["Arvinas LLC, New Haven, Connecticut 06511, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arvinas LLC, New Haven, Connecticut 06511, USA","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016866989","display_name":"Craig M. Crews","orcid":"https://orcid.org/0000-0002-8456-2005","observed_orcids":["https://orcid.org/0000-0002-8456-2005"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig M. Crews","raw_affiliation_strings":["Department of Molecular, Cellular, and Developmental Biology; Department of Chemistry; and Department of Pharmacology, Yale University, New Haven, Connecticut 06511, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular, Cellular, and Developmental Biology; Department of Chemistry; and Department of Pharmacology, Yale University, New Haven, Connecticut 06511, USA;","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6346,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.54734934,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"2","issue":"1","first_page":"41","last_page":"58"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.9980000257492065},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.6620000004768372},{"id":"https://openalex.org/keywords/e3-ubiquitin-ligase","display_name":"E3 ubiquitin ligase","score":0.8650000095367432},{"id":"https://openalex.org/keywords/polyubiquitination","display_name":"polyubiquitination","score":0.9010000228881836},{"id":"https://openalex.org/keywords/26s-proteasome","display_name":"26S proteasome","score":0.9729999899864197},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9580000042915344},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.996999979019165},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/undruggable-proteins","display_name":"undruggable proteins","score":0.8619999885559082},{"id":"https://openalex.org/keywords/targeted-protein-degradation","display_name":"targeted protein degradation","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.8191450238227844},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.7107457518577576},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.6578361988067627},{"id":"https://openalex.org/C2781307694","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Proteolysis","level":3,"score":0.6368748545646667},{"id":"https://openalex.org/C2992195973","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Protein degradation","level":2,"score":0.5944811105728149},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5864488482475281},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5479745864868164},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49295687675476074},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.4777792692184448},{"id":"https://openalex.org/C131312102","wikidata":"https://www.wikidata.org/wiki/Q5423632","display_name":"F-box protein","level":5,"score":0.4168161153793335},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.41515910625457764},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.321874737739563},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3206937313079834},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2648876905441284},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10262799263000488},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08602207899093628},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06998533010482788}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1146/annurev-cancerbio-030617-050430","doi":"https://doi.org/10.1146/annurev-cancerbio-030617-050430","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev-cancerbio-030617-050430","pdf_url":null,"source":{"id":"https://openalex.org/S4210178937","display_name":"Annual Review of Cancer Biology","issn_l":"2472-3428","issn":["2472-3428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Cancer Biology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":106,"referenced_works":["https://openalex.org/W1488181101","https://openalex.org/W1512690422","https://openalex.org/W1523117612","https://openalex.org/W1527383154","https://openalex.org/W1565539350","https://openalex.org/W1597238753","https://openalex.org/W1848444843","https://openalex.org/W1923567272","https://openalex.org/W1969236463","https://openalex.org/W1973999018","https://openalex.org/W1976134037","https://openalex.org/W1978226159","https://openalex.org/W1982166691","https://openalex.org/W1982810302","https://openalex.org/W1982819726","https://openalex.org/W1985299376","https://openalex.org/W1985762436","https://openalex.org/W1986231077","https://openalex.org/W1988013217","https://openalex.org/W1994344724","https://openalex.org/W1995079678","https://openalex.org/W1997087919","https://openalex.org/W1997952190","https://openalex.org/W1998944024","https://openalex.org/W2002395443","https://openalex.org/W2003163964","https://openalex.org/W2003632864","https://openalex.org/W2008779407","https://openalex.org/W2009693397","https://openalex.org/W2009949436","https://openalex.org/W2011138994","https://openalex.org/W2015273986","https://openalex.org/W2015345028","https://openalex.org/W2015878656","https://openalex.org/W2015997780","https://openalex.org/W2023586989","https://openalex.org/W2025031463","https://openalex.org/W2039864977","https://openalex.org/W2042216712","https://openalex.org/W2043526119","https://openalex.org/W2045435533","https://openalex.org/W2046219070","https://openalex.org/W2048964430","https://openalex.org/W2049706724","https://openalex.org/W2052787205","https://openalex.org/W2055568018","https://openalex.org/W2057460011","https://openalex.org/W2064299413","https://openalex.org/W2064815984","https://openalex.org/W2065136554","https://openalex.org/W2066713758","https://openalex.org/W2068412287","https://openalex.org/W2068455168","https://openalex.org/W2070514471","https://openalex.org/W2071909842","https://openalex.org/W2076319483","https://openalex.org/W2077141448","https://openalex.org/W2083469632","https://openalex.org/W2083665788","https://openalex.org/W2083926838","https://openalex.org/W2084897147","https://openalex.org/W2085609942","https://openalex.org/W2087393141","https://openalex.org/W2091246008","https://openalex.org/W2091269867","https://openalex.org/W2091577612","https://openalex.org/W2097933346","https://openalex.org/W2107257265","https://openalex.org/W2109378990","https://openalex.org/W2109541969","https://openalex.org/W2109790992","https://openalex.org/W2110221241","https://openalex.org/W2117170436","https://openalex.org/W2118428599","https://openalex.org/W2120572492","https://openalex.org/W2125828985","https://openalex.org/W2129129812","https://openalex.org/W2131441324","https://openalex.org/W2134178604","https://openalex.org/W2136860804","https://openalex.org/W2140230121","https://openalex.org/W2144941480","https://openalex.org/W2147270075","https://openalex.org/W2147718842","https://openalex.org/W2147744317","https://openalex.org/W2151683271","https://openalex.org/W2155388460","https://openalex.org/W2161413435","https://openalex.org/W2165080661","https://openalex.org/W2167786713","https://openalex.org/W2171450779","https://openalex.org/W2176682109","https://openalex.org/W2230373777","https://openalex.org/W2292464399","https://openalex.org/W2314042185","https://openalex.org/W2325609367","https://openalex.org/W2340678549","https://openalex.org/W2409568753","https://openalex.org/W2470671857","https://openalex.org/W2520252945","https://openalex.org/W2527752336","https://openalex.org/W2563465351","https://openalex.org/W2585495993","https://openalex.org/W2589078946","https://openalex.org/W2597078857","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W4294941551","https://openalex.org/W7136767500","https://openalex.org/W4301037378","https://openalex.org/W3042697772","https://openalex.org/W3177376878","https://openalex.org/W7220544678","https://openalex.org/W2072504963","https://openalex.org/W4415320829","https://openalex.org/W4416292831","https://openalex.org/W4402421412"],"abstract_inverted_index":{"The":[0],"ubiquitin-proteasome":[1],"system":[2],"plays":[3],"a":[4,16,90,96,124],"central":[5],"role":[6],"in":[7,11,39],"regulating":[8],"protein":[9],"homeostasis":[10],"mammalian":[12],"cells.":[13],"It":[14],"is":[15],"multistep":[17],"process":[18,37],"involving":[19],"the":[20,30,40,48,57,60,67,138],"polyubiquitination":[21],"of":[22,35,42,50,59,69,108],"proteins":[23,43],"prior":[24],"to":[25,47,56,83,89,98,127,133,140],"their":[26],"proteolytic":[27],"degradation":[28],"by":[29],"26S":[31],"proteasome":[32,61],"complex.":[33],"Blockade":[34],"this":[36],"results":[38],"accumulation":[41],"that":[44,121],"are":[45,79],"deleterious":[46],"survival":[49],"cancer":[51],"cells":[52],"and":[53,64,72,100,132],"has":[54],"led":[55],"approval":[58],"inhibitors":[62],"bortezomib":[63],"carfilzomib":[65],"for":[66],"treatment":[68],"multiple":[70],"myeloma":[71],"mantle":[73],"cell":[74,130],"lymphoma.":[75],"Proteolysis-targeting":[76],"chimeras":[77],"(PROTACs)":[78],"bifunctional":[80],"molecules":[81],"designed":[82],"recruit":[84],"an":[85],"E3":[86],"ubiquitin":[87],"ligase":[88],"specific":[91,102],"target":[92,141],"protein,":[93],"thereby":[94],"providing":[95],"mechanism":[97],"ubiquitinate":[99],"degrade":[101],"pathological":[103],"proteins.":[104,144],"A":[105],"significant":[106],"body":[107],"preclinical":[109],"data,":[110],"generated":[111],"since":[112],"PROTACs":[113,122],"were":[114],"first":[115],"introduced":[116],"15":[117],"years":[118],"ago,":[119],"demonstrates":[120],"provide":[123],"robust":[125],"approach":[126],"expose":[128],"new":[129],"biology":[131],"generate":[134],"novel":[135],"therapeutics":[136],"with":[137],"potential":[139],"currently":[142],"undruggable":[143]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-05-05T00:00:00"}